A 13-Gene Signature Prognostic of HPV-Negative OSCC: Discovery and External Validation

We identified and validated a 13-gene signature that is considerably better than tumor stage in predicting survival of patients with HPV-negative OSCCs. Further evaluation of this gene signature as a prognostic marker in other populations of patients with HPV-negative OSCC is warranted.